Request for Covid-19 Impact Assessment of this Report

Diagnostic and Biotech

Dialysis Concentrate Market by Type (Acid Concentrates, Bicarbonate Concentrates, and Peritoneal Dialysis Fluid), Application (Hemodialysis and Peritoneal Dialysis), and Dialysis Site (Hospitals, Clinics & Dialysis Centers, and Home Dialysis): Global Opportunity Analysis and Industry Forecast, 2021–2030.

  • ALL4676939
  • 232 Pages
  • September 2021
  • Diagnostic and Biotech
Download Sample    Get Discount   
 
The global dialysis concentrate market was valued at $2,692.6 million in 2020 and is projected to reach $4,531.5 million by 2030, registering a CAGR of 5.40% from 2021 to 2030.

Dialysis concentrates or dialysis fluid mainly consists of three components. It includes purified water, glucose, and electrolytes. The concentration of electrolytes nearly resembles that occurs naturally in the blood. Dialysis concentrate is prepared according to the individual's requirement that helps to regulate electrolyte and acid-base balance, in turn, removing metabolic waste products from the body. There are primarily two types of concentrates for hemodialysis, bicarbonate (base) and acid. Acid and bicarbonate are mixed with treated water, which then forms the dialysis fluid (dialysate). Hemodialysate is the solute and fluid that flows through the dialyzer during the process of hemodialysis. Once the acid concentrates, water and bicarbonate concentrate are combined. The final dialysate can contain up to 3 buffer components. These components depend on the amount of acid concentrate used.

The main driving factors that drive growth of the dialysis concentrate market include, surge in incidences of kidney related diseases and problems associated with kidney transplants as kidney transplantation involves a major surgery, a donor match, and a lifetime regime of immunosuppressant medications to prevent body refutation against the organ. In addition, rise in prevalence of lifestyle and chronic diseases, such as obesity, diabetes, and hypertension, is projected to further supplement the global dialysis concentrate market growth. Conversely, rise in complications related to dialysis treatment, such as infections, hypotension, fluid overload, and access point bleeding, is expected to obstruct growth of the market in the coming years. Similarly, reimbursement policy concerns in emerging nations impedes the growth of the market, as reimbursement for dialysis varies widely in terms of amount & duration between these countries and does not necessarily cover real treatment costs, further discouraging patients and physicians for considering the policy usage. On the other hand, shift in preference of patients toward home hemodialysis (HHD), owing to its effective and patient-centered approach is expected to offer profitable opportunities for the growth of the market during the forecast period.

The global dialysis concentrate market is segmented on the basis of type, application, dialysis site, and region to provide a detailed assessment of the market. By type, it is divided into acid concentrates, bicarbonate concentrates, and peritoneal dialysis fluid. By application, it is classified into hemodialysis and peritoneal dialysis. Based on dialysis site, it is categorized into hospital, clinics & dialysis centers, and home dialysis. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the dialysis concentrate market along with the current trends and future estimations to explain the imminent investment pockets.

• A comprehensive analysis of the factors that drive and restrict the market growth is provided in the report.

• Comprehensive quantitative analysis of the industry from 2020 to 2030 is provided to enable the stakeholders to capitalize on the prevailing market opportunities.

• Extensive analysis of the key segments of the industry helps to understand the application and products of dialysis concentrate used across the globe.

• Key market players and their strategies have been analyzed to understand the competitive outlook of the market.

KEY MARKET SEGMENTS

By Type

• Acid Concentrates

• Bicarbonate Concentrates

• Peritoneal Dialysis Fluid

By Application

• Hemodialysis

• Peritoneal Dialysis

By Dialysis Site

• Hospital

• Clinics & Dialysis Centers

• Home Dialysis

By Region

• North America

o U.S.

o Canada

o Mexico

• Europe

o Germany

o France

o UK

o Italy

o Spain

o Rest of Europe

• Asia-Pacific

o Japan

o China

o India

o Australia

o South Korea

o Rest of Asia-Pacific

• LAMEA

o Brazil

o Saudi Arabia

o South Africa

o Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

• Asahi Kasei Medical Co. Ltd

• B. Braun Melsungen AG

• Baxter

• Dialysis Medical Solutions

• Farmasol

• Fresenius Medical Care

• Hemoclean

• Medites Pharma, spol. s.r.o.

• Nikkiso

• Nipro Renal Solutions

CHAPTER 1:INTRODUCTION

1.1.Report description

1.2.Key benefits for stakeholders

1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research

1.4.2.Primary research

1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study

2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope

3.2.Key findings

3.2.1.Top investment pockets

3.2.2.Top winning strategies

3.3.Porter’s five force analysis

3.4.Top player positioning, 2020

3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Surge in incidences of kidney diseases

3.5.1.2.Issues associated with kidney transplants

3.5.1.3.Rise in prevalence of lifestyle and chronic diseases

3.5.2.Restraints

3.5.2.1.Complications in dialysis treatment

3.5.2.2.Reimbursement policy concerns in emerging nations

3.5.3.Opportunities

3.5.3.1.Shift in preference of patients for home hemodialysis

3.5.4.Impact analysis

3.6.COVID-19 Impact analysis on the dialysis concentrate market

CHAPTER 4:DIALYSIS CONCENTRATE MARKET, BY TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Acid Concentrates

4.2.1.Key market trends, growth factors, and opportunities

4.2.2.Market size and forecast, by region

4.2.3.Market analysis, by country

4.3.Bicarbonate Concentrates

4.3.1.Key market trends, growth factors, and opportunities

4.3.2.Market size and forecast

4.3.3.Market analysis, by country

4.4.Peritoneal Dialysis Fluid

4.4.1.Key market trends, growth factors, and opportunities

4.4.2.Market size and forecast

4.4.3.Market analysis, by country

CHAPTER 5:DIALYSIS CONCENTRATE MARKET, BY APPLICATION

5.1.Overview

5.1.1.Market size and forecast

5.2.Hemodialysis

5.2.1.Key market trends, growth factors, and opportunities

5.2.2.Market size and forecast, by region

5.2.2.1.Market size and forecast for hemodialysis, by dialysis site

5.2.3.Market analysis, by country

5.3.Peritoneal Dialysis

5.3.1.Key market trends, growth factors, and opportunities

5.3.2.Market size and forecast, by region

5.3.2.1.Market size and forecast for peritoneal dialysis, by dialysis site

5.3.3.Market analysis, by country

CHAPTER 6:DIALYSIS CONCENTRATE MARKET, DIALYSIS SITE

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals

6.2.1.Key market trends, growth factors, and opportunities

6.2.2.Market size and forecast, by region

6.2.3.Market analysis, by country

6.3.Clinics & Dialysis Centers

6.3.1.Key market trends, growth factors, and opportunities

6.3.2.Market size and forecast, by region

6.3.3.Market analysis, by country

6.4.Home Dialysis

6.4.1.Key market trends, growth factors, and opportunities

6.4.2.Market size and forecast

6.4.3.Market analysis, by country

CHAPTER 7:DIALYSIS CONCENTRATE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities

7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. dialysis concentrate market, by type

7.2.2.1.2.U.S. dialysis concentrate market, by application

7.2.2.1.3.U.S. dialysis concentrate market, by dialysis site

7.2.2.2.Canada

7.2.2.2.1.Canada dialysis concentrate market, by type

7.2.2.2.2.Canada dialysis concentrate market, by application

7.2.2.2.3.Canada dialysis concentrate market, by dialysis site

7.2.2.3.Mexico

7.2.2.3.1.Mexico dialysis concentrate market, by type

7.2.2.3.2.Mexico dialysis concentrate market, by application

7.2.2.3.3.Mexico dialysis concentrate market, by dialysis site

7.2.3.North America market size and forecast, by type

7.2.4.North America market size and forecast, by application

7.2.5.North America market size and forecast, by dialysis site

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities

7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany dialysis concentrate market, by type

7.3.2.1.2.Germany dialysis concentrate market, by application

7.3.2.1.3.Germany dialysis concentrate market, by dialysis site

7.3.2.2.France

7.3.2.2.1.France dialysis concentrate market, by type

7.3.2.2.2.France dialysis concentrate market, by application

7.3.2.2.3.France dialysis concentrate market, by dialysis site

7.3.2.3.UK

7.3.2.3.1.UK dialysis concentrate market, by type

7.3.2.3.2.UK dialysis concentrate market, by application

7.3.2.3.3.UK dialysis concentrate market, by dialysis site

7.3.2.4.Italy

7.3.2.4.1.Italy dialysis concentrate market, by type

7.3.2.4.2.Italy dialysis concentrate market, by application

7.3.2.4.3.Italy dialysis concentrate market, by dialysis site

7.3.2.5.Spain

7.3.2.5.1.Spain dialysis concentrate market, by type

7.3.2.5.2.Spain dialysis concentrate market, by application

7.3.2.5.3.Spain dialysis concentrate market, by dialysis site

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe dialysis concentrate market, by type

7.3.2.6.2.Rest of Europe dialysis concentrate market, by application

7.3.2.6.3.Rest of Europe dialysis concentrate market, by dialysis site

7.3.3.Europe market size and forecast, by type

7.3.4.Europe market size and forecast, by application

7.3.5.Europe market size and forecast, by dialysis site

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities

7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan dialysis concentrate market, by type

7.4.2.1.2.Japan dialysis concentrate market, by application

7.4.2.1.3.Japan dialysis concentrate market, by dialysis site

7.4.2.2.China

7.4.2.2.1.China dialysis concentrate market, by type

7.4.2.2.2.China dialysis concentrate market, by application

7.4.2.2.3.China dialysis concentrate market, by dialysis site

7.4.2.3.Australia

7.4.2.3.1.Australia dialysis concentrate market, by type

7.4.2.3.2.Australia dialysis concentrate market, by application

7.4.2.3.3.Australia dialysis concentrate market, by dialysis site

7.4.2.4.India

7.4.2.4.1.India dialysis concentrate market, by type

7.4.2.4.2.India dialysis concentrate market, by application

7.4.2.4.3.India dialysis concentrate market, by dialysis site

7.4.2.5.South Korea

7.4.2.5.1.South Korea dialysis concentrate market, by Type

7.4.2.5.2.South Korea dialysis concentrate market, by application

7.4.2.5.3.South Korea dialysis concentrate market, by dialysis site

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Rest of Asia-Pacific dialysis concentrate market, by type

7.4.2.6.2.Rest of Asia-Pacific dialysis concentrate market, by application

7.4.2.6.3.Rest of Asia-Pacific dialysis concentrate market, by dialysis site

7.4.3.Asia-Pacific market size and forecast, by type

7.4.4.Asia-Pacific market size and forecast, by application

7.4.5.Asia-Pacific market size and forecast, by dialysis site

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities

7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil dialysis concentrate market, by type

7.5.2.1.2.Brazil dialysis concentrate market, by application

7.5.2.1.3.Brazil dialysis concentrate market, by dialysis site

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia dialysis concentrate market, by type

7.5.2.2.2.Saudi Arabia dialysis concentrate market, by application

7.5.2.2.3.Saudi Arabia dialysis concentrate market, by dialysis site

7.5.2.3.South Africa

7.5.2.3.1.South Africa dialysis concentrate market, by type

7.5.2.3.2.South Africa dialysis concentrate market, by application

7.5.2.3.3.South Africa dialysis concentrate market, by dialysis site

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA dialysis concentrate market, by type

7.5.2.4.2.Rest of LAMEA dialysis concentrate market, by application

7.5.2.4.3.Rest of LAMEA dialysis concentrate market, by dialysis site

7.5.3.LAMEA market size and forecast, by type

7.5.4.LAMEA market size and forecast, by application

7.5.5.LAMEA market size and forecast, by dialysis site

CHAPTER 8:COMPANY PROFILES

8.1.ASAHI KASEI CORPORATION

8.1.1.Company overview

8.1.2.Company snapshot

8.1.3.Operating business segments

8.1.4.Product portfolio

8.1.5.Business performance

8.2.BAXTER INTERNATIONAL INC.

8.2.1.Company overview

8.2.2.Company snapshot

8.2.3.Operating business segments

8.2.4.Product portfolio

8.2.5.Business performance

8.3.B BRAUN MELSUNGEN AG

8.3.1.Company overview

8.3.2.Company snapshot

8.3.3.Operating business segments

8.3.4.Product portfolio

8.3.5.Business performance

8.4.DIALYSIS MEDICAL SOLUTION

8.4.1.Company overview

8.4.2.Company snapshot

8.4.3.Operating business segments

8.4.4.Product portfolio

8.5.FARMASOL

8.5.1.Company overview

8.5.2.Company snapshot

8.5.3.Operating business segments

8.5.4.Product portfolio

8.6.FRESENIUS SE AND CO. KGAA

8.6.1.Company overview

8.6.2.Company snapshot

8.6.3.Operating business segments

8.6.4.Product portfolio

8.6.5.Business performance

8.7.HEMOCLEAN CO., LTD.

8.7.1.Company overview

8.7.2.Company snapshot

8.7.3.Operating business segments

8.7.4.Product portfolio

8.8.MEDITES PHARMA, SPOL. S.R.O.

8.8.1.Company overview

8.8.2.Company snapshot

8.8.3.Operating business segments

8.8.4.Product portfolio

8.9.NIKKISO CO. LTD.

8.9.1.Company overview

8.9.2.Company snapshot

8.9.3.Operating business segments

8.9.4.Product portfolio

8.9.5.Business performance

8.10.NIPRO CORPORATION

8.10.1.Company overview

8.10.2.Company snapshot

8.10.3.Operating business segments

8.10.4.Product portfolio

8.10.5.Business performance

LIST OF TABLES

TABLE 01.GLOBAL DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 02.DIALYSIS CONCENTRATE MARKET FOR ACID CONCENTRATES, BY REGION, 2020-2030($MILLION)

TABLE 03.DIALYSIS CONCENTRATE MARKET FOR BICARBONATE CONCENTRATES, BY REGION, 2020-2030($MILLION)

TABLE 04.DIALYSIS CONCENTRATE MARKET FOR PERITONEAL DIALYSIS FLUID, BY REGION, 2020-2030($MILLION)

TABLE 05.GLOBAL DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 06.DIALYSIS CONCENTRATE MARKET FOR HEMODIALYSIS, BY REGION, 2020-2030($MILLION)

TABLE 07.DIALYSIS CONCENTRATE MARKET FOR HEMODIALYSIS, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 08.DIALYSIS CONCENTRATE MARKET FOR PERITONEAL DIALYSIS, BY REGION, 2020-2030($MILLION)

TABLE 09.DIALYSIS CONCENTRATE MARKET FOR HEMODIALYSIS, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 10.GLOBAL DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 11.DIALYSIS CONCENTRATE MARKET FOR HOSPITALS, BY REGION, 2020-2030($MILLION)

TABLE 12.DIALYSIS CONCENTRATE MARKET FOR CLINICS & DIALYSIS CENTERS, BY REGION, 2020-2030($MILLION)

TABLE 13.DIALYSIS CONCENTRATE MARKET FOR HOME DIALYSIS, BY REGION, 2020-2030($MILLION)

TABLE 14.DIALYSIS CONCENTRATE MARKET, BY REGION, 2020-2030($MILLION)

TABLE 15.NORTH AMERICA DIALYSIS CONCENTRATE MARKET, BY COUNTRY, 2020-2030($MILLION)

TABLE 16.U.S. DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 17.U.S. DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 18.U.S. DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 19.CANADA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 20.CANADA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 21.CANADA DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 22.MEXICO DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 23.MEXICO DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 24.MEXICO DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 25.NORTH AMERICA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 26.NORTH AMERICA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 27.NORTH AMERICA DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 28.EUROPE DIALYSIS CONCENTRATE MARKET, BY COUNTRY, 2020-2030($MILLION)

TABLE 29.GERMANY DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 30.GERMANY DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 31.GERMANY DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 32.FRANCE DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 33.FRANCE DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 34.FRANCE DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 35.UK DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 36.UK DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 37.UK DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 38.ITALY DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 39.ITALY DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 40.ITALY DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 41.SPAIN DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 42.SPAIN DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 43.SPAIN DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 44.REST OF EUROPE DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 45.REST OF EUROPE DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 46.REST OF EUROPE DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 47.EUROPE DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 48.EUROPE DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 49.EUROPE DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 50.ASIA-PACIFIC DIALYSIS CONCENTRATE MARKET, BY COUNTRY, 2020-2030($MILLION)

TABLE 51.JAPAN DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 52.JAPAN DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 53.JAPAN DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 54.CHINA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 55.CHINA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 56.CHINA DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 57.AUSTRALIA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 58.AUSTRALIA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 59.AUSTRALIA DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 60.INDIA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 61.INDIA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 62.INDIA DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 63.SOUTH KOREA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 64.SOUTH KOREA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 65.SOUTH KOREA DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 66.REST OF ASIA-PACIFIC DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 67.REST OF ASIA-PACIFIC DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 68.REST OF ASIA-PACIFIC DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 69.ASIA-PACIFIC DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 70.ASIA-PACIFIC DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 71.ASIA-PACIFIC DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 72.LAMEA DIALYSIS CONCENTRATE MARKET, BY COUNTRY, 2020-2030($MILLION)

TABLE 73.BRAZIL DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 74.BRAZIL DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 75.BRAZIL DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 76.SAUDI ARABIA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 77.SAUDI ARABIA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 78.SAUDI ARABIA DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 79.SOUTH AFRICA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 80.SOUTH AFRICA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 81.SOUTH AFRICA DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE 2020-2030($MILLION)

TABLE 82.REST OF LAMEA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 83.REST OF LAMEA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 84.REST OF LAMEA DIALYSIS CONCENTRATE MARKET, DIALYSIS SITE, 2020-2030($MILLION)

TABLE 85.LAMEA DIALYSIS CONCENTRATE MARKET, BY TYPE, 2020-2030($MILLION)

TABLE 86.LAMEA DIALYSIS CONCENTRATE MARKET, BY APPLICATION, 2020-2030($MILLION)

TABLE 87.LAMEA DIALYSIS CONCENTRATE MARKET, BY DIALYSIS SITE, 2020-2030($MILLION)

TABLE 88.ASAHI KASEI: COMPANY SNAPSHOT

TABLE 89.ASAHI KASEI: OPERATING SEGMENTS

TABLE 90.ASAHI KASEI: PRODUCT PORTFOLIO

TABLE 91.BAXTER: COMPANY SNAPSHOT

TABLE 92.BAXTER: OPERATING SEGMENTS

TABLE 93.BAXTER: PRODUCT PORTFOLIO

TABLE 94.B BRAUN: COMPANY SNAPSHOT

TABLE 95.B BRAUN: OPERATING SEGMENTS

TABLE 96.B BRAUN: PRODUCT PORTFOLIO

TABLE 97.DIALYSIS MEDICAL SOLUTION: COMPANY SNAPSHOT

TABLE 98.DIALYSIS MEDICAL SOLUTION: OPERATING SEGMENTS

TABLE 99.DIALYSIS MEDICAL SOLUTION: PRODUCT PORTFOLIO

TABLE 100.FARMASOL: COMPANY SNAPSHOT

TABLE 101.FARMASOL: OPERATING SEGMENTS

TABLE 102.FARMASOL: PRODUCT PORTFOLIO

TABLE 103.FRESENIUS: COMPANY SNAPSHOT

TABLE 104.FRESENIUS: OPERATING SEGMENTS

TABLE 105.FRESENIUS: PRODUCT PORTFOLIO

TABLE 106.HEMOCLEAN: COMPANY SNAPSHOT

TABLE 107.HEMOCLEAN: OPERATING SEGMENTS

TABLE 108.HEMOCLEAN: PRODUCT PORTFOLIO

TABLE 109.MEDITES PHARMA: COMPANY SNAPSHOT

TABLE 110.MEDITES PHARMA: OPERATING SEGMENTS

TABLE 111.MEDITES PHARMA: PRODUCT PORTFOLIO

TABLE 112.NIKKISO: COMPANY SNAPSHOT

TABLE 113.NIKKISO: OPERATING SEGMENTS

TABLE 114.NIKKISO: PRODUCT PORTFOLIO

TABLE 115.NIPRO: COMPANY SNAPSHOT

TABLE 116.NIPRO: OPERATING SEGMENTS

TABLE 117.NIPRO: PRODUCT PORTFOLIO

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

2017-2021 UK Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $6,100.  DataPack (test volumes, sales forecasts, supplier shares) $3,950.

Summary

This comprehensive report contains 409 pages, 35 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the UK coagulation testing market duri...

  • Publish Date: February 7, 2017
  • $750
2017-2021 US Hemostasis Diagnostics Market: Emerging Opportunities and Growth Strategies for Instrument and Reagent Suppliers

Complete report $9,600.  DataPack (test volumes, sales forecasts, supplier shares) $6,200.

Summary

This comprehensive report contains 424 pages, 37 tables, and is designed to help current suppliers and potential market entrants identify and evaluate business opportunities emerging in the US coagulation testing market during the...

  • Publish Date: February 7, 2017
  • $750
2017-2021 Immunohematology and Infectious Disease Screening Market: Competitive Analysis of Major Suppliers and Emerging Market Entrants

This new report from VPGMarketResearch.com provides strategic assessments of major blood banking product suppliers and emerging market entrants. The report presents analyses of major current and emerging suppliers in terms of their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Con...

  • Publish Date: February 7, 2017
  • $750